Global Biologics Outsourcing Market

Biologics Outsourcing Comprehensive Study by Type (Antibody, Recombinant, Protein, Vaccines, Others), Application (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research, Other), Sources (Microbial, Mammalian, Others) Players and Region - Global Market Outlook to 2028

Biologics Outsourcing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Biologics Outsourcing Market Scope
Biologics outsourcing are therapeutic entities composed of proteins, sugars or nucleic acids made from natural sources such as micro-organisms, human, and animal. Biologics can also include live attenuated microorganisms, allergenic extracts, human cells, and tissue transplantation, gene therapies, and cell therapies. Small molecule drugs, these drugs are intended for the treatment of diseases and medical conditions. This is projected the growth of the biologics market in the market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledBoehringer Ingelheim (Germany), Catalent, Inc. (United States), Genscript Biotech (United States), Innovent Biologics, Inc. (China), Shanghai Medicilon inc. (united States), GL Biochem Corporation (China), Horizon Discovery Group plc (United Kingdom), Selexis (Switzerland), Lonza Group (Switzerland) and Abzena plc (United Kigdom)
CAGR%


The Players having a strong hold in the market are Boehringer Ingelheim, Catalent, Inc., Genscript Biotech, and Innovent Biologics, Inc.. Research Analyst at AMA estimates that United States and European Players will contribute to the maximum growth of Global Biologics Outsourcing market throughout the predicted period.

Boehringer Ingelheim (Germany), Catalent, Inc. (United States), Genscript Biotech (United States), Innovent Biologics, Inc. (China), Shanghai Medicilon inc. (united States), GL Biochem Corporation (China), Horizon Discovery Group plc (United Kingdom), Selexis (Switzerland), Lonza Group (Switzerland) and Abzena plc (United Kigdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are GVK Biosciences Private Limited (India) and Syngene International Limited (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Biologics Outsourcing market by Type , by Application (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research and Other) and Region with country level break-up.

On the basis of geography, the market of Biologics Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
On 3, September 2019, Evonik has announced that the company has acquired the Endexo surface modification business from Interface Biologics.



Influencing Trend:
Growing Contract Manufacturing in Developing Economies

Market Growth Drivers:
Rising Manufacturing Efficiency and Productivity in Developing Economies and Increasing Monitoring and Process Control

Opportunities:
Industry Growth Demand for Efficiency International Biomfg Centers is Creates the Opportunites for Market and Rising Investments in the Research & Development of Biologics are Significantly Propelling Growth of the Market

Key Target Audience
Biologics Outsourcing Providers, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors and Other

Report Objectives / Segmentation Covered

By Type
  • Antibody
  • Recombinant
  • Protein
  • Vaccines
  • Others
By Application
  • Vaccine & Therapeutics Development
  • Blood & Blood Related Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue Related Products Testing
  • Stem Cell Research
  • Other
By Sources
  • Microbial
  • Mammalian
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Manufacturing Efficiency and Productivity in Developing Economies
      • 3.2.2. Increasing Monitoring and Process Control
    • 3.3. Market Trends
      • 3.3.1. Growing Contract Manufacturing in Developing Economies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biologics Outsourcing, by Type, Application, Sources and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Biologics Outsourcing (Value)
      • 5.2.1. Global Biologics Outsourcing by: Type (Value)
        • 5.2.1.1. Antibody
        • 5.2.1.2. Recombinant
        • 5.2.1.3. Protein
        • 5.2.1.4. Vaccines
        • 5.2.1.5. Others
      • 5.2.2. Global Biologics Outsourcing by: Application (Value)
        • 5.2.2.1. Vaccine & Therapeutics Development
        • 5.2.2.2. Blood & Blood Related Products Testing
        • 5.2.2.3. Cellular and Gene Therapy
        • 5.2.2.4. Tissue and Tissue Related Products Testing
        • 5.2.2.5. Stem Cell Research
        • 5.2.2.6. Other
      • 5.2.3. Global Biologics Outsourcing by: Sources (Value)
        • 5.2.3.1. Microbial
        • 5.2.3.2. Mammalian
        • 5.2.3.3. Others
      • 5.2.4. Global Biologics Outsourcing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biologics Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer Ingelheim (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Catalent, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genscript Biotech (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Innovent Biologics, Inc. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Shanghai Medicilon inc. (united States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GL Biochem Corporation (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Horizon Discovery Group plc (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Selexis (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lonza Group (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abzena plc (United Kigdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biologics Outsourcing Sale, by Type, Application, Sources and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Biologics Outsourcing (Value)
      • 7.2.1. Global Biologics Outsourcing by: Type (Value)
        • 7.2.1.1. Antibody
        • 7.2.1.2. Recombinant
        • 7.2.1.3. Protein
        • 7.2.1.4. Vaccines
        • 7.2.1.5. Others
      • 7.2.2. Global Biologics Outsourcing by: Application (Value)
        • 7.2.2.1. Vaccine & Therapeutics Development
        • 7.2.2.2. Blood & Blood Related Products Testing
        • 7.2.2.3. Cellular and Gene Therapy
        • 7.2.2.4. Tissue and Tissue Related Products Testing
        • 7.2.2.5. Stem Cell Research
        • 7.2.2.6. Other
      • 7.2.3. Global Biologics Outsourcing by: Sources (Value)
        • 7.2.3.1. Microbial
        • 7.2.3.2. Mammalian
        • 7.2.3.3. Others
      • 7.2.4. Global Biologics Outsourcing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biologics Outsourcing: by Type(USD Million)
  • Table 2. Biologics Outsourcing Antibody , by Region USD Million (2017-2022)
  • Table 3. Biologics Outsourcing Recombinant , by Region USD Million (2017-2022)
  • Table 4. Biologics Outsourcing Protein , by Region USD Million (2017-2022)
  • Table 5. Biologics Outsourcing Vaccines , by Region USD Million (2017-2022)
  • Table 6. Biologics Outsourcing Others , by Region USD Million (2017-2022)
  • Table 7. Biologics Outsourcing: by Application(USD Million)
  • Table 8. Biologics Outsourcing Vaccine & Therapeutics Development , by Region USD Million (2017-2022)
  • Table 9. Biologics Outsourcing Blood & Blood Related Products Testing , by Region USD Million (2017-2022)
  • Table 10. Biologics Outsourcing Cellular and Gene Therapy , by Region USD Million (2017-2022)
  • Table 11. Biologics Outsourcing Tissue and Tissue Related Products Testing , by Region USD Million (2017-2022)
  • Table 12. Biologics Outsourcing Stem Cell Research , by Region USD Million (2017-2022)
  • Table 13. Biologics Outsourcing Other , by Region USD Million (2017-2022)
  • Table 14. Biologics Outsourcing: by Sources(USD Million)
  • Table 15. Biologics Outsourcing Microbial , by Region USD Million (2017-2022)
  • Table 16. Biologics Outsourcing Mammalian , by Region USD Million (2017-2022)
  • Table 17. Biologics Outsourcing Others , by Region USD Million (2017-2022)
  • Table 18. South America Biologics Outsourcing, by Country USD Million (2017-2022)
  • Table 19. South America Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 20. South America Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 21. South America Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 22. Brazil Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 23. Brazil Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 24. Brazil Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 25. Argentina Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 26. Argentina Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 27. Argentina Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 28. Rest of South America Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 29. Rest of South America Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 30. Rest of South America Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 31. Asia Pacific Biologics Outsourcing, by Country USD Million (2017-2022)
  • Table 32. Asia Pacific Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 33. Asia Pacific Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 34. Asia Pacific Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 35. China Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 36. China Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 37. China Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 38. Japan Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 39. Japan Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 40. Japan Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 41. India Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 42. India Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 43. India Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 44. South Korea Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 45. South Korea Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 46. South Korea Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 47. Taiwan Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 48. Taiwan Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 49. Taiwan Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 50. Australia Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 51. Australia Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 52. Australia Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 56. Europe Biologics Outsourcing, by Country USD Million (2017-2022)
  • Table 57. Europe Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 58. Europe Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 59. Europe Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 60. Germany Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 61. Germany Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 62. Germany Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 63. France Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 64. France Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 65. France Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 66. Italy Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 67. Italy Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 68. Italy Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 69. United Kingdom Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 70. United Kingdom Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 71. United Kingdom Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 72. Netherlands Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 73. Netherlands Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 74. Netherlands Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 75. Rest of Europe Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 76. Rest of Europe Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 77. Rest of Europe Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 78. MEA Biologics Outsourcing, by Country USD Million (2017-2022)
  • Table 79. MEA Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 80. MEA Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 81. MEA Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 82. Middle East Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 83. Middle East Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 84. Middle East Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 85. Africa Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 86. Africa Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 87. Africa Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 88. North America Biologics Outsourcing, by Country USD Million (2017-2022)
  • Table 89. North America Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 90. North America Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 91. North America Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 92. United States Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 93. United States Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 94. United States Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 95. Canada Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 96. Canada Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 97. Canada Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 98. Mexico Biologics Outsourcing, by Type USD Million (2017-2022)
  • Table 99. Mexico Biologics Outsourcing, by Application USD Million (2017-2022)
  • Table 100. Mexico Biologics Outsourcing, by Sources USD Million (2017-2022)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Biologics Outsourcing: by Type(USD Million)
  • Table 112. Biologics Outsourcing Antibody , by Region USD Million (2023-2028)
  • Table 113. Biologics Outsourcing Recombinant , by Region USD Million (2023-2028)
  • Table 114. Biologics Outsourcing Protein , by Region USD Million (2023-2028)
  • Table 115. Biologics Outsourcing Vaccines , by Region USD Million (2023-2028)
  • Table 116. Biologics Outsourcing Others , by Region USD Million (2023-2028)
  • Table 117. Biologics Outsourcing: by Application(USD Million)
  • Table 118. Biologics Outsourcing Vaccine & Therapeutics Development , by Region USD Million (2023-2028)
  • Table 119. Biologics Outsourcing Blood & Blood Related Products Testing , by Region USD Million (2023-2028)
  • Table 120. Biologics Outsourcing Cellular and Gene Therapy , by Region USD Million (2023-2028)
  • Table 121. Biologics Outsourcing Tissue and Tissue Related Products Testing , by Region USD Million (2023-2028)
  • Table 122. Biologics Outsourcing Stem Cell Research , by Region USD Million (2023-2028)
  • Table 123. Biologics Outsourcing Other , by Region USD Million (2023-2028)
  • Table 124. Biologics Outsourcing: by Sources(USD Million)
  • Table 125. Biologics Outsourcing Microbial , by Region USD Million (2023-2028)
  • Table 126. Biologics Outsourcing Mammalian , by Region USD Million (2023-2028)
  • Table 127. Biologics Outsourcing Others , by Region USD Million (2023-2028)
  • Table 128. South America Biologics Outsourcing, by Country USD Million (2023-2028)
  • Table 129. South America Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 130. South America Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 131. South America Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 132. Brazil Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 133. Brazil Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 134. Brazil Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 135. Argentina Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 136. Argentina Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 137. Argentina Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 138. Rest of South America Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 139. Rest of South America Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 140. Rest of South America Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 141. Asia Pacific Biologics Outsourcing, by Country USD Million (2023-2028)
  • Table 142. Asia Pacific Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 143. Asia Pacific Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 144. Asia Pacific Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 145. China Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 146. China Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 147. China Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 148. Japan Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 149. Japan Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 150. Japan Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 151. India Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 152. India Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 153. India Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 154. South Korea Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 155. South Korea Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 156. South Korea Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 157. Taiwan Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 158. Taiwan Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 159. Taiwan Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 160. Australia Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 161. Australia Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 162. Australia Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 163. Rest of Asia-Pacific Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 164. Rest of Asia-Pacific Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 165. Rest of Asia-Pacific Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 166. Europe Biologics Outsourcing, by Country USD Million (2023-2028)
  • Table 167. Europe Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 168. Europe Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 169. Europe Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 170. Germany Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 171. Germany Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 172. Germany Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 173. France Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 174. France Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 175. France Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 176. Italy Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 177. Italy Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 178. Italy Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 179. United Kingdom Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 180. United Kingdom Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 181. United Kingdom Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 182. Netherlands Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 183. Netherlands Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 184. Netherlands Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 185. Rest of Europe Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 186. Rest of Europe Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 187. Rest of Europe Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 188. MEA Biologics Outsourcing, by Country USD Million (2023-2028)
  • Table 189. MEA Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 190. MEA Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 191. MEA Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 192. Middle East Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 193. Middle East Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 194. Middle East Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 195. Africa Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 196. Africa Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 197. Africa Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 198. North America Biologics Outsourcing, by Country USD Million (2023-2028)
  • Table 199. North America Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 200. North America Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 201. North America Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 202. United States Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 203. United States Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 204. United States Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 205. Canada Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 206. Canada Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 207. Canada Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 208. Mexico Biologics Outsourcing, by Type USD Million (2023-2028)
  • Table 209. Mexico Biologics Outsourcing, by Application USD Million (2023-2028)
  • Table 210. Mexico Biologics Outsourcing, by Sources USD Million (2023-2028)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biologics Outsourcing: by Type USD Million (2017-2022)
  • Figure 5. Global Biologics Outsourcing: by Application USD Million (2017-2022)
  • Figure 6. Global Biologics Outsourcing: by Sources USD Million (2017-2022)
  • Figure 7. South America Biologics Outsourcing Share (%), by Country
  • Figure 8. Asia Pacific Biologics Outsourcing Share (%), by Country
  • Figure 9. Europe Biologics Outsourcing Share (%), by Country
  • Figure 10. MEA Biologics Outsourcing Share (%), by Country
  • Figure 11. North America Biologics Outsourcing Share (%), by Country
  • Figure 12. Global Biologics Outsourcing share by Players 2022 (%)
  • Figure 13. Global Biologics Outsourcing share by Players (Top 3) 2022(%)
  • Figure 14. Global Biologics Outsourcing share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Boehringer Ingelheim (Germany) Revenue: by Geography 2022
  • Figure 18. Catalent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Catalent, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. Genscript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 21. Genscript Biotech (United States) Revenue: by Geography 2022
  • Figure 22. Innovent Biologics, Inc. (China) Revenue, Net Income and Gross profit
  • Figure 23. Innovent Biologics, Inc. (China) Revenue: by Geography 2022
  • Figure 24. Shanghai Medicilon inc. (united States) Revenue, Net Income and Gross profit
  • Figure 25. Shanghai Medicilon inc. (united States) Revenue: by Geography 2022
  • Figure 26. GL Biochem Corporation (China) Revenue, Net Income and Gross profit
  • Figure 27. GL Biochem Corporation (China) Revenue: by Geography 2022
  • Figure 28. Horizon Discovery Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Horizon Discovery Group plc (United Kingdom) Revenue: by Geography 2022
  • Figure 30. Selexis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Selexis (Switzerland) Revenue: by Geography 2022
  • Figure 32. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Lonza Group (Switzerland) Revenue: by Geography 2022
  • Figure 34. Abzena plc (United Kigdom) Revenue, Net Income and Gross profit
  • Figure 35. Abzena plc (United Kigdom) Revenue: by Geography 2022
  • Figure 36. Global Biologics Outsourcing: by Type USD Million (2023-2028)
  • Figure 37. Global Biologics Outsourcing: by Application USD Million (2023-2028)
  • Figure 38. Global Biologics Outsourcing: by Sources USD Million (2023-2028)
  • Figure 39. South America Biologics Outsourcing Share (%), by Country
  • Figure 40. Asia Pacific Biologics Outsourcing Share (%), by Country
  • Figure 41. Europe Biologics Outsourcing Share (%), by Country
  • Figure 42. MEA Biologics Outsourcing Share (%), by Country
  • Figure 43. North America Biologics Outsourcing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boehringer Ingelheim (Germany)
  • Catalent, Inc. (United States)
  • Genscript Biotech (United States)
  • Innovent Biologics, Inc. (China)
  • Shanghai Medicilon inc. (united States)
  • GL Biochem Corporation (China)
  • Horizon Discovery Group plc (United Kingdom)
  • Selexis (Switzerland)
  • Lonza Group (Switzerland)
  • Abzena plc (United Kigdom)
Additional players considered in the study are as follows:
GVK Biosciences Private Limited (India) , Syngene International Limited (India)
Select User Access Type

Key Highlights of Report


May 2023 226 Pages 77 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biologics Outsourcing Market Quantitative research analysis
Global Biologics Outsourcing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Biologics Outsourcing Market are by type [Antibody, Recombinant, Protein, Vaccines and Others], by end use application [Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research and Other].
The Biologics Outsourcing Market is gaining popularity and expected to see strong valuation by 2028.
  • Rising Manufacturing Efficiency and Productivity in Developing Economies
  • Increasing Monitoring and Process Control

Know More About Global Biologics Outsourcing Market Report?

Have a Query? Click Here

Other Related Reports

Dental Preventive Supplies Comprehensive Study by Type (Toothpaste, Mouthwash, Dental Sealants, Dental Prophylaxis, Others), Distribution Channel (Online {E-Commerce}, Offline {Hospital Pharmacies, P...
$ 3650
Cancer Genome Sequencing Comprehensive Study by Type (Second Generation (SOLiD Sequencing, Pyro-Sequencing, Bridge Amplification Sequencing Technology), Third Generation (Ion Semiconductor Sequencing...
$ 3650
Rehabilitation Swimming Pools Comprehensive Study by Type (Portable, Stationary), Treatment Type (Orthopedics, Obesity Crisis, Sports Rehabilitation, Others), End User (Human, Veterinary) Players and...
$ 3500
Patient Engagement Technology Comprehensive Study by Application (Health Management, Social and Behavioral, Home Health), Technology (Licensing fees, Implementation fees, Annual license maintenance f...
$ 3750
Lung Cancer Vaccines - Comprehensive Study by Type (Preventive Lung Cancer Vaccines, Therapeutic Lung Cancer Vaccines), Application (Hospitals, Clinics, Pharmacies, Vaccines Centers, Other, End user)...
$ 3450
Knee Replacement Surgery Comprehensive Study by Type (Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, Complex/Revision Knee Replacement), Application (Hospitals, Ambulatory Sur...
$ 3450